Clinical trial
Prospective Non-Interventional Study on Structum® in Adult Patients With Osteoarthritis
NCT06623773 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Non-Interventional Study on Structum® in Adult Patients With Osteoarthritis
- Lead sponsor
- Pierre Fabre Medicament
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 12, 2023
- Completion date
- October 28, 2024
- Enrollment
- 136 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.